相关实验视频

Updated: Jul 14, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

大麻植物精油:化学特征和抗菌活性对抗甲基西林耐药的Staphylococcus pseudintermedius

Ylenia Pieracci¹, Maria Francesca Bozzini¹, Carolina Campanini²

¹Dipartimento di Farmacia, Università di Pisa, Pisa, Italy.

Natural product research

|September 4, 2024

概括

大麻草本精油表现出强大的抗菌活性,对抗多药耐药的 Staphylococcus pseudintermedius. 这些来自大麻的油具有协同作用,为传统抗生素提供了有希望的替代品.

科学领域:

植物化学植物化学
微生物学微生物学
兽医医学兽医医学兽医医学

背景情况:

大麻sativa L. 精油 (EO) 具有多样化的生物活性.
作为抗生素的替代品,EO正在被探索,以对抗耐药细菌.
伪中间体葡萄球菌 (Staphylococcus pseudintermedius) 是狗感染中的重要病原体.

研究的目的:

评估Cannabis sativa L. EO. 的体外抑制和杀菌活性.
评估两种大麻基因型的叶子和花朵EO的疗效.
为了测试这些EO对多药耐药性和甲素耐药性Staphylococcus pseudintermedius进行测试.

主要方法:

精油是从两种Cannabis sativa基因型的叶子和花朵中提取的.
气色谱-质谱法 (GC-MS) 用于化学分析 (六烯,植物性大麻素).
在体外抗微生物测试中确定了针对Staphylococcus pseudintermedius菌株的抑制和杀菌度.

主要成果:

这两种EO都富含甲碳化合物 (β-甲,α-甲) 并含有不同的植物性大麻素水平.
含有较高植物性大麻素的EO显示出优异的抑制和杀菌活性.
大麻sativa EO表现出比单独β-caryophyllene更大的活性,表明协同效应.

结论:

大麻草本精油在体外具有显著的抗菌特性,可以对抗耐药的Staphylococcus pseudintermedius.
植物性大麻素含量似乎与增强的抗微生物疗效相关.
欧成分之间的协同相互作用有助于它们强大的杀菌作用,表明治疗潜力.

关键词:

在MBCBC中,MBC是MBC.在MIC中,MIC是MIC,MIC是MIC.斯塔菲洛科克菌伪中间体.狗皮肤疾病狗皮肤疾病 α-氨基氨酸是什么?这是一种β-Caryophyllene.

更多相关视频

Antimicrobial Characterization of Advanced Materials for Bioengineering Applications

Antimicrobial Characterization of Advanced Materials for Bioengineering Applications

Published on: August 4, 2018

Author Spotlight: An Antimicrobial Fabric Using Nano-Herbal Encapsulation of Essential Oils

Author Spotlight: An Antimicrobial Fabric Using Nano-Herbal Encapsulation of Essential Oils

Published on: April 7, 2023

相关概念视频

Antimicrobial Effectiveness

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...

Staphylococcal Skin Infections

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...

Mechanism of Antibiotic Resistance in MRSA

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...

Clinical Significance of Antibiotic Resistance

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...